Clinical Trials

Clinical Trials

As a comprehensive health care provider, we offer our patients the opportunity to participate in cutting-edge clinical trials close to home. Current research studies are available in:


Cancer

Disease Site       Title  Status     
 AML/MDS Registry (not a treatment trial) Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry Click here for more information on this trial
Bladder      CALGB 90601: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma Click here for more information on this trial 
Breast Spectrum: Open-Label, Dose-Ranging Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Patients With Breast Cancer Who Are Candidates for Adjuvant and Neoadjuvant Chemotherapy With the Docetaxel + Cyclophosphamide (TC) Regimen Click here for more information on this trial
Breast     S1202: Randomized Placebo Controlled Phase III Study of Duloxetinefor Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer Click here for more information on this trial
Breast     SWOG S1007: A phase III, Randomized Clinical trial of standard adjuant endocrine therapy +/- chemotheraphy in patients 1-3 positive nodes, hormone receptor-positive and her2-negative Breast Cancer with recurrence score (RS) of 25 or less. RXPONDER: A clinical trial RX for positive node, endocrine responsive Breast Cancer Click here for more information on this trial
Colon
CALGB 80702: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer
Click here for more information on this trial 
Lung
ECOG E5508: Randomized Phase III Study of Maintenance Therapy With Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Click here for more information on this trial
Lung
1200.167 ADAM: A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Click here for more information on this trial
Prostate     Alliance A031201: Phase III trial of enzalutamide (NSC# 766085) versus enzalutamide, abiraterone and prednisone for castration resistant metastatic prostate cancer Click here for more information on this trial
 

Cardiology

Disease
Site
Title Status 
A-Fib Registry (Not a treatment trial)
GLORIA AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Click here for more information on this trial
Post MI for Diabetic and Metabolic Syndrome patients CIRT: The Cardiovascular Inflammation Reduction Trial (CIRT) Click here for more information on this trial
Acute MI (Not a treatment trial) SILVER AMI: Risk Stratification in Older Persons With Acute Myocardial Infarction Click here for more information on this trial


For more information about clinical research at Samaritan, contact 541-768-6349.